KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Return on Equity (2020 - 2026)

Organon has reported Return on Equity over the past 7 years, most recently at 0.0% for Q1 2026.

  • For Q1 2026, Return on Equity fell 1.0% year-over-year to 0.0%; the TTM value through Mar 2026 reached 0.0%, down 1.0%, while the annual FY2025 figure was 0.0%, 4.0% down from the prior year.
  • Return on Equity for Q1 2026 was 0.0% at Organon, up from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.1% in Q2 2024 and troughed at 0.95% in Q1 2024.
  • A 5-year average of 0.06% and a median of 0.0% in 2026 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: tumbled -95bps in 2024 and later surged 97bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2022, then plummeted by -107135bps to 0.03% in 2023, then surged by 158bps to 0.02% in 2024, then crashed by -87bps to 0.0% in 2025, then surged by 32bps to 0.0% in 2026.
  • Business Quant data shows Return on Equity for OGN at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.